Druggio Logo

Druggio

Atopic dermatitis

Atopic dermatitis (AD) is a relapsing chronic inflammatory skin disease characterized by eczematous skin lesions and intense pruritus. A genetic defect in the filaggrin (FLG) protein and/or environmental factors are thought to cause AD by disrupting the epidermis. This disruption, in turn, results in contact between immune cells in the dermis and antigens from the external environment leading to intense itching, scratching, and inflammation. Apart from FLG, recent genome-wide association studies (GWASs) have identified many susceptibility loci of atopic dermatitis with genome-wide significance.

Drugs that treat Atopic dermatitis

Moizerto

Approval date

2021/9/27

Cibinqo

Made by

Pfizer

Approval date

2021/9/27

Corectim

Approval date

2020/1/23

Dupixent

Made by

Sanofi

Approval date

2018/1/19

Allegra

Made by

Sanofi

Approval date

2000/9/22